Titles
- New regulations broadening employer exemptions to contraceptive coverage: impact on women2
- Parks After Dark evaluation report2
- Peripheral vascular atherectomy devices: premarket notification [510(k)] submissions : guidance for industry and Food and Drug Administration staff2
- Policy for temporary compounding of certain alcohol-based hand sanitizer products during the public health emergency: immediately in effect guidance for industry2
- Racial and ethnic disparities in influenza and pneumococcal immunization rates among Medicare beneficiaries2
- Recommendations to reduce the possible risk of transmission of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease by blood and blood components2
- Reductions in deaths and hospitalizations associated with COVID-19 vaccinations among Medicare beneficiaries: full year 2021 estimates2
- Referencing approved drug products in ANDA submissions2
- Requests for feedback and meetings for medical device submissions: the Q-Submission Program : guidance for industry and Food and Drug Administration staff2
- Risk evaluation and mitigation strategies: modifications and revisions2
- Submission of plans for cigarette packages and cigarette advertisements (revised)2
- Syringe services programs: impact on the spread of communicable diseases2
- Technical specifications for submitting clinical trial data sets for treatment of noncirrhotic nonalcoholic steatohepatitis (NASH)2
- Temporary policy for preparation of certain alcohol-based hand sanitizer products during the public health emergency (COVID-19)2
- Tezepelumab for severe asthma: final report2
- Understanding coverage considerations for COVID-19 vaccines and treatments2
- Will people be healthy enough to work longer?2
- Wrong-site orthopedic operations on the extremities: the Pennsylvania experience2
- "Acting bigger" by partnering with government1
- "Consumer-directed" health plans: implications for health care quality and cost1